Gonul VARAN KOC, Gül GÜRSOY, Besime Halis COPUR, Hanife COPUR EKSİLER, Ahmet YİLDİRİM, Suheyla GORAR, Cavit CULHA, Yalcin ARAL

Relationship between osteocalcin levels and gestational diabetes mellitus

Osteocalcin is an osteoblast-derived protein mainly acting on bone formation. There is growing evidence that osteocalcin has an important role in glucose metabolism. It was not fully elucidated in gestational diabetes mellitus. The aim of our study was to investigate osteocalcin levels in gestational diabetes mellitus and its subgroups. We performed a case–control cross sectional study and evaluated all the demographic and anthropometric parameters of 80 pregnant women whose age and body mass indices similar, half of them having normal glucose tolerance (NGT) and the other half having gestational diabetes mellitus (GDM). We compared osteocalcin, calcium metabolism parameters, glucose, lipid levels, insulin resistance parameters, and investigated correlations of all parameters in NGT and GDM. We also analyzed GDM subgroups, which were classified according to age, parity, body mass index (BMI), and vitamin D levels. Osteocalcin levels were increased in patients with GDM and in older, multiparous, with low vitamin D or high body mass index GDM subgroups but these increases were not statistically significant (P>0.05). There was a positive correlation between osteocalcin and C peptide in GDM group and also in GDM subgroups with age≥30, multiparous, vitamin D≥20 ng/ml or BMI≥30 kg/m2 (r=0.424, P=0.006; r=0.460, P=0.011; r=0.408, P=0.017; r=0.520, P=0.013; r=0.603, P=0.002 respectively). We also found a negative correlation between Osteocalcin and HDLcholesterol in GDM and in multiparous, vitamin D≥20 ng/ml or BMI

PDF

___

Rosen CJ, Donahau LR, Hunter SJ. Insulin like growth factors and bone: the osteoporosis connection. Proc Soc Exp Biol Med. 1994; 206:83-102.

Hinoi E, Karsenty G. Reciprocal regulation of bone and energy metabolism. J Muskuloskelet Neuronal Interact. 2008;8:351-3.

Mizokami A, Yasutake Y, Gao J, et al. Osteocalcin induces release of glucagon-like peptide-1 and thereby stimulates insulin secretion in mice. PLoS One. 2013;8:e57375.

Mizokami A, Yasutake Y, Higashi S, et al. Oral administration of osteocalcin improves glucose utilization by stimulating glucagon-like peptide-1 secretion. Bone. 2014;69 C:68–79.

Akin O, Göl K, Aktürk M, et al. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Gynecol Endocrinol. 2003;17:19-29.

Pater A, Sypniewska G, Pileki O. Biochemical markers of bone activity in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2010;23:81-6.

Winhofer Y, Handisurya A, Tura A, et al. Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care. 2010;1:13943.

8.Saucedo R, Rico G, Vega G, et al. Osteocalcin, under-carboxylated osteocalcin are not associated with gestational diabetes mellitus but are inversely associated with leptin in non-diabetic women. J Endocrinol Invest. 2015;38:519-26.

Yoon BK, Lee J, Choi D, et al. Changes in biochemical bone markers during pregnancy and puerperium. J Korean Med Sci. 2000;15:189-93.

10. Tabatabaei N, Giguère Y, Forest JC, et al. Osteocalcin is higher across pregnancy in Caucasian women with gestational diabetes mellitus. Can J Diabetes. 2014;38:307-13.

11. Telejko B, Kalejta K, Kuzmicki M, et al. The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes. Ann Agric Environ Med. 2015;22:307- 12.

12. Martinez ME, Catalan P, Lisbona A, et al. Serum osteocalcin concentrations in diabetic pregnant women and their newborns. Horm Metab Res. 1994;26:338-42.

13. Metzger BE, Gabbe SG, Persson B. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:67682.

14. Bilotta FL, Arcidiacono B, Messineo S, et al. Insulin and osteocalcin: further evidence for a mutual cross-talk. Endocrine. 2018;59:622-32.

15. Ng KW, Martin TJ. New functions for old hormones: Bone as an endocrine organ. Mol Cell Endocrinol. 2009;310:1–2.

16. Lombardi G, Perego S, Luzi L, et al. A four-season molecule: osteocalcin. Updates in its physiological roles. Endocrine. 2015;48:394–404.

17. Murshed M, Schinke T, McKee MD, et al. Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol. 2004;165:625–30.

18. Mizokami A, Kawakubo-Yasukochi T, Hirata M. Osteocalcin and its endocrine functions. Biochem. Pharmacol. 2017;132:1–8.

19. Ducy P, Desbois C, Boyce B, et al. Increased bone formation in osteocalcindeficient mice. Nature. 1996;382:448–52.

20. Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456–69.

21. Wei J, Ferron M, Clarke CJ, et al. Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J Clin Invest. 2014;124:1–13.

22. Cole DE, Gundberg CM, Stirk LJ, et al. Changing osteocalcin concentrations during pregnancy and lactation: implications for maternal mineral metabolism. J Clin Endocrinol Metab. 1987;65:290– 4.

23. Papastefanou M, Eleftheriades M, Kappou D, et al. Maternal serum osteocalcin at 11-14 weeks of gestation in gestational diabetes mellitus. Eur J Clin Invest. 2015;45:1025–31.

24. Douglas AS, Miller MH, Reid DM, et al. Seasonal differences in biochemical parameters of bone remodelling. J Clin Pathol. 1996;49:284-9.

25. Bao YQ. Relationship between serum osteocalcin and glycemic variability in type 2 diabetes. Clin Exp Pharmacol Physiol. 2011;38:50-4.

26. Pittas AG, Harris SS, Eliades M, et al. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab. 2009;94:82732.

27. Chin KY, Ima-Nirwana IN, Ahmad F, et al. Serum osteocalcin is significantly related to indices of obesity and lipid profile in Malaysian men. Int J Med Sci. 2014;11:151-7.

28. Chen X, Wu Y, Liu L, et al. Osteocalcin is inversely associated with glucose levels in middle-aged Tibetan men with different degrees of glucose tolerance. Diabetes Metabol Resh. Rev. 2014;30:476-82. 29.

29. Levinger L, Scott D, Nicholson GC, et al. Uncarboxylated osteocalcin, muscle strength and indices of bone health in older women. Bone 2014; 64: 8-12.

30. Fernandez-Real JM, Izquierdo M, Ortega F, et al. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab. 2009;94:237-45.

31. Hauschka PV, Lian JB, Cole DE, et al. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiological Reviews. 1989;69:9901047.

32. Martinez-Portilla RJ, Villafan-Bernal JR, Lip-Sosa DL, et al. Osteocalcin serum levels in gestational diabetes mellitus and their intrinsic and extrinsic determinants: systematic rewiev and metaanalysis. J Diabetes Res. 2018;2018:4986735.

33. Srichomkwun P, Houngngam N, Pasatrat, S, et al. Undercarboxylated osteocalcin is associated with insulin resistance, but not adiponectin, during pregnancy. Endocrine. 2016;53:129–35.

34. Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnes Res. 2004;17:126–36.